Prs9 - Switching From Subcutaneous Treprostinil to Inhaled Treprostinil in Pulmonary Arterial Hypertension Treatment and Economic Impact Evaluation

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2403
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Rapid Transition From Inhaled Iloprost to Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2013English

Tolerability and Clinical Efficacy of Inhaled Treprostinil in Patients With Group 1 Pulmonary Arterial Hypertension

Therapeutic Advances in Chronic Disease
Medicine
2018English

Treatment Satisfaction Is Associated With Improved Quality of Life in Patients Treated With Inhaled Treprostinil for Pulmonary Arterial Hypertension

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2013English

Impact of Switching From Epoprostenol to IV Treprostinil on Treatment Satisfaction and Quality of Life in Patients With Pulmonary Hypertension

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Transition of Stable Pediatric Patients With Pulmonary Arterial Hypertension From Intravenous Epoprostenol to Intravenous Treprostinil

American Journal of Cardiology
Cardiovascular MedicineCardiology
2007English

Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2017English

Long-Term Treprostinil in Pulmonary Arterial Hypertension: Is the Glass Half Full or Half Empty?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Inhaled Iloprost for Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy